Juno Minerals Limited remained an exploration-stage iron-ore company across FY2021-FY2025. The record separates statutory loss, exploration cash spending, project carrying values and funding: a FY2023 impairment and later funding/deposit cash movements matter more to the five-year picture than a conventional revenue trend.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Statutory cash at 30 June 2025.
Includes the Mount Mason deposit received in advance.
Excludes the A$5.705m asset held for sale.
Operating cash outflow; distinct from accounting loss.
FY2021 runs from incorporation on 10 November 2020 to 30 June 2021; FY2022-FY2025 are years ended 30 June. The company was formed through the Jupiter Mines demerger and became the independent owner of the Central Yilgarn Iron Project.
The selected financial statements use Australian dollars. The review does not infer a production or product-sales revenue series for this explorer.
Juno was formed through the Jupiter Mines demerger and commenced ASX trading on 14 May 2021. The Central Yilgarn acquisition was paid in shares, not cash, establishing an exploration-stage balance sheet rather than an operating-revenue base.
Contracting packages were re-priced amid permitting, logistics, iron-ore-price and industry-cost pressures before a financial investment decision.
A$9.215m of capitalised exploration and evaluation expenditure was impaired following an iron-ore-price downturn. The company also disclosed a material uncertainty related to going concern.
Share issue proceeds were A$3.639m and cash raising costs A$0.101m, while operating and investing cash remained outflows. The issuer reported no impairment from its FY2024 AASB 6 assessment, and noted employee remuneration capitalised to exploration projects.
The agreement contemplated A$6m cash plus a 2% FOB royalty. A$3m was recorded as a deposit received in advance and the A$5.705m carrying value was held for sale at year-end; the remaining A$3m was payable on completion.
Closing cash fell from A$7.838m at the end of the short FY2021 period to A$1.606m at FY2023, then rose to A$4.309m by FY2025. The later recovery was not a sustained operating-cash turnaround: FY2024 had financing inflow, while FY2025 investing inflow included the Mount Mason deposit received in advance.
FY2025 total liabilities were A$4.233m. The financial statements identify receipt of the remaining A$3m Mount Mason consideration as necessary to the going-concern basis and state that non-completion would create material uncertainty; this report does not treat the outstanding amount as cash or a completed disposal.
A$ million
AI-generated presentation · values from Financial position, liquidity and project carrying value; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Statutory cash-flow lanes; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 7.838 | 4.421 | 1.606 | 2.138 | 4.309 |
| Total assets | 33.806 | 32.594 | 22.981 | 25.736 | 29.364 |
| Total liabilities | 0.479 | 0.158 | 0.340 | 0.212 | 4.233 |
| Total equity | 33.328 | 32.436 | 22.641 | 25.525 | 25.131 |
| Exploration and evaluation assets — closing balance | 25.729 | 27.934 | 21.042 | 23.450 | 19.290 |
FY2021 covers 10 November 2020 to 30 June 2021 and is not annualised.
At FY2025, A$5.705m of Mount Mason was reclassified to current assets held for sale, so it is not included in the closing exploration-and-evaluation row.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net cash used in operating activities | (0.497) | (1.019) | (0.619) | (0.441) | (0.122) |
| Net cash from/(used in) investing activities | (0.499) | (2.384) | (2.197) | (2.564) | 1.474 |
| Net cash from/(used in) financing activities | 8.834 | (0.013) | 0.000 | 3.538 | 0.819 |
Parentheses denote cash outflow. The FY2023 financing line is expressly reported as nil.
FY2025 investing cash flow includes A$3.000m deposits received in advance; it is not recurring investment income.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Juno’s reported loss was materially higher in FY2023 because of the A$9.215m Mount Mason exploration impairment. Exploration cash expenditure is shown separately from the closing exploration asset and from the accounting loss: each answers a different question about the project portfolio.
FY2025 operating receipts included A$1.005m described as other income and customer receipts. The deferred-revenue note supports A$0.098m as water-extraction-fee income recognised through profit or loss, with A$0.652m remaining deferred; the broader receipt label is not treated as product sales or matched mechanically to that income.
A$ million
AI-generated presentation · values from Loss and exploration-and-evaluation cash spending; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Loss and exploration-and-evaluation cash spending; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss after income tax | (1.135) | (0.892) | (9.795) | (0.655) | (1.213) |
| Exploration and evaluation cash outflow | (0.486) | (2.384) | (2.181) | (2.542) | (1.526) |
FY2024 uses the later FY2025 comparative (A$2.542m) to preserve the same exploration-and-evaluation cash-spending basis, rather than mixing it with FY2024’s broader net-investing subtotal.
Exploration cash outflow, closing exploration asset and accounting loss are separate measures.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Employee benefits expense | (0.548) | (0.066) | (0.149) | (0.155) |
| Other expenses | (0.586) | (0.863) | (0.959) | (1.018) |
FY2021 other expenses use the FY2022 comparative presentation, which includes the separately presented FY2021 administrative expense. FY2021 remains a shorter reporting period.
A complete comparable FY2025 profit-or-loss cost breakdown was not available in the retained packet and is not reconstructed from cash-flow reconciliations.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Other income | 0.040 | 0.467 | 0.502 |
| Finance income | 0.002 | 0.069 | 0.028 |
These are reported income lines, not product sales.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Customer prepayment received | 0.750 |
| Recognised through profit or loss | 0.098 |
| Closing deferred revenue (current + non-current) | 0.652 |
Reported reconciliation: opening nil + A$0.750m customer prepayment − A$0.098m recognised = A$0.652m closing deferred revenue.
The A$1.005m “other income and customer receipts” cash-flow line is broader than this recognised-income figure and is not treated as product-sales revenue.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration and evaluation assets increased through FY2022, then declined after the FY2023 impairment. FY2024’s assessment recorded no further impairment; employee remuneration expense was reported net of A$0.217m capitalised to exploration projects (FY2023: A$0.213m), a cost-classification consideration when comparing expense lines.
At 30 June 2025 Mount Mason’s A$5.705m carrying value was reclassified to assets held for sale. The remaining A$19.290m closing exploration-and-evaluation balance and the held-for-sale balance should be read together, but neither is an annual exploration cash-spending figure.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Share issue proceeds | 3.639 | 0.819 |
| Payments to suppliers and employees | (1.010) | (1.144) |
| Other income and customer receipts | 0.540 | 1.005 |
FY2024 share proceeds less cash raising costs reconcile to the financing inflow shown in the cash-flow table. FY2025 share proceeds equal the reported financing inflow because capital raising costs are shown as nil.
Other income and customer receipts are operating-cash lines, not a substitute for recognised product-sales income.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.